Cargando…
Drug Repurposing Using Gene Co-Expression and Module Preservation Analysis in Acute Respiratory Distress Syndrome (ARDS), Systemic Inflammatory Response Syndrome (SIRS), Sepsis, and COVID-19
SIMPLE SUMMARY: The COVID-19 pandemic has caused a global standstill. The advent of vaccines has significantly hindered viral transmission, paving the way back to normalcy. However, post-COVID-19 treatment is still of utmost concern as people continue to suffer from “cytokine storms” or excessive in...
Autores principales: | Mailem, Ryan Christian, Tayo, Lemmuel L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775208/ https://www.ncbi.nlm.nih.gov/pubmed/36552336 http://dx.doi.org/10.3390/biology11121827 |
Ejemplares similares
-
Prospects of Novel and Repurposed Immunomodulatory Drugs against Acute Respiratory Distress Syndrome (ARDS) Associated with COVID-19 Disease
por: Nayak, Smruti Sudha, et al.
Publicado: (2023) -
Navigating the Gene Co-Expression Network and Drug Repurposing Opportunities for Brain Disorders Associated with Neurocognitive Impairment
por: Manuel, Mathew Timothy Artuz, et al.
Publicado: (2023) -
Repurposing tetracyclines for acute respiratory distress syndrome (ARDS) and severe COVID-19: a critical discussion of recent publications
por: Garrido-Mesa, Jose, et al.
Publicado: (2022) -
Kratom-Induced Acute Respiratory Distress Syndrome (ARDS)
por: Chinnappan, Justine, et al.
Publicado: (2023) -
Mechanisms of Pulmonary Hypertension in Acute Respiratory Distress Syndrome (ARDS)
por: Revercomb, Lucy, et al.
Publicado: (2021)